Drug Therapy for Generalized Anxiety Disorder Among the Elderly
Anxiety Disorders, Generalized Anxiety Disorder
About this trial
This is an interventional treatment trial for Anxiety Disorders focused on measuring Anxiety, Elderly, Aged, Serotonin Reuptake Inhibitors, SSRI, SERT
Eligibility Criteria
Inclusion Criteria: Diagnosis of at least moderately severe generalized anxiety disorder (GAD) Exclusion Criteria: Serious suicide risk or psychiatric instability that would affect study participation Dementia Substance abuse, such as alcoholism, within 6 months prior to study entry Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder, or bipolar disorder Unstable medical conditions that would preclude the use of escitalopram Use of certain psychotropics that can not be safely tapered or discontinued for at least 2 weeks prior to and during the study Use of neuroleptics that are absorbed over a prolonged period of time within 6 weeks prior to study entry
Sites / Locations
- University of Pittsburgh Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Escitalopram (1)
Placebo (2)
Escitalopram
Placebo